Simulations Plus, Inc.
- SLP
- NASDAQ
- Application software
- Drug Discovery Software
- AI/ML Modeling (Pharma)
$18.50
Quote Oct 6, 2026, 08:00 PM UTC
+0.43%over the last month
Max drawdown −0.3%From 1-month high 0.0%3 months +0.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Simulations Plus
Simulations Plus, Inc. (SLP) is a worldwide developer of sophisticated software and services aimed at enhancing drug discovery and development processes. The company employs artificial intelligence and machine learning technologies to create tools for modeling, simulation, and predicting molecular characteristics.
Where the money comes from
Q3 2026 revenue $21.9M
- License and Maintenance$12.6M57.6%
- Service$9.3M42.4%
Sector
Technology
Industry
Application software
Exchange
NASDAQ
Employees
213
Founded
1996
Market value
$374.2M
Quote Oct 6
Analyst target
$18.50
+0.0% from here
Floor
$18.36
0.8% below price
Resistance
$18.52
0.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SLPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free